MedTrace Logo

Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?

NCT05640596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 363

Last updated 2022-12-12

No results posted yet for this study

Summary

Use of antenatal corticosteroids therapy has increased since the 2000s. The benefits of such a therapy on premature newborns are scientifically and internationally recognized.

Nevertheless, few studies have been conducted to investigate the impact of this antenatal corticosteroid therapy on full-term newborns (\> 36 weeks' gestation).

The aim of this study is to compare the birth parameters of full-term newborns exposed or not to antenatal corticosteroid therapy.

Conditions

  • Growth Retardation

Interventions

DRUG

Betamethasone

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2020-12-31
Completion
2022-11-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05640596 on ClinicalTrials.gov